Keywords: mdrna, sells, manufacturing, facilities, generic, candidate, par

MDRNA sells manufacturing facilities and generic candidate to Par Pharma

Article | 08 April 2009

Print This

US biotechnology firm MDRNA has sold its Hauppauge, New York, manufacturing facilities to Par Pharmaceuticals, along with its Abbreviated New ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in